Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions,
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …

Simple Summary Metabolic-dysfunction-associated steatotic liver disease (previously known
as non-alcoholic fatty liver disease) is a term for a range of liver conditions in which excess …

Palmitic acid (PA) is the most common fatty acid in humans and mediates palmitoylation
through its conversion into palmitoyl coenzyme A. Although palmitoylation affects many …

Radiomic image features are becoming a promising non-invasive method to obtain
quantitative measurements for tumour classification and therapy response assessment in …

Hepatocellular carcinoma (HCC) has a poor prognosis and a low survival rate. Drugs
without side effects are desperately needed since chemotherapy has a negative effect on …

Introduction Hepatocellular carcinoma (HCC) is the most common primary liver cancer and
fourth-leading cause of cancer death. While drug discovery to improve disease survival was …

Simple Summary Hepatocellular carcinoma accounts for around 75% of all liver cancers,
and represents the fourth most common cause of cancer-related deaths worldwide …

Simple Summary STAT3 is a major oncogenic transcription factor that is constitutively
activated in many types of human cancers, including hepatocellular carcinoma (HCC) and …

Background Circular RNA hsa_circ_0061395 (circ_0061395) has been reported to
accelerate the advancement of hepatocellular carcinoma (HCC). However, the regulatory …

Targeting cytokinesis can suppress tumor growth by blocking cell division and promoting
apoptosis. We aimed to characterize key cytokinesis regulator in hepatocellular carcinoma …